$Oscar Health, Inc.(OSCR)$ $Hims & Hers Health Inc.(HIMS)$ $Clover Health Corp(CLOV)$ 📈🔥🚀 $OSCR in the $16s: Back Where Smart Money Gets Involved 🚀🔥📈

I like this setup a lot. It’s not breaking down, it’s coiling. The structure is tightening with precision.

Oscar Health just completed a textbook backtest of its monthly bias zone, holding the golden pocket near the 200-day and reclaiming the anchored VWAP from March. This is a strategic liquidity zone. More than 2.1 million shares exchanged hands during the flush, nearly twice its 10-day average, followed by stabilisation and controlled re-accumulation.

Technically, price is compressing between $16.32 and $16.69. RSI is resetting with bullish divergence emerging, and MACD is flattening at the zero line. If $16.69 breaks with conviction, I’m eyeing a move to $18.65 and then a reclaim of the prior high at $23.57. That represents over 40% potential upside, with a measured move extension pointing to $25.50.

💡 This is more than just a chart setup. Oscar is one of the few tech-enabled health insurers scaling efficiently. Membership growth is running at 41% year-on-year, while SG&A expense improved in Q1. The company is projecting 500%+ EPS growth this year and is on track for profitability ahead of sector peers.

From a valuation perspective, $OSCR remains deeply discounted. Based on forward EV/EBITDA and relative to its 2021 IPO benchmarks, the stock is currently undervalued by approximately 41%. With 20%+ revenue CAGR, expanding margins, and a moat in digital-first care delivery, Oscar’s model supports re-rating in both growth and value frameworks.

🧠 One underappreciated feature of this setup is the compression happening within a rising volume base. The current pattern reflects price acceptance, not rejection. Institutional players tend to build size under key resistance levels before directional pivots.

⚠️ Key risk to monitor is the $15.80 zone. A clean break below that would negate the pattern and reopen downside gaps. As long as we hold above that level, the risk-reward remains highly favourable with upside targets clearly defined.

📊 What I’m watching:

• Clean breakout above $16.69 with volume confirmation

• Q2 earnings catalysts including medical loss ratio guidance

• Institutional flows and short interest adjustments

• Sector sentiment across healthtech and managed care

Oscar isn’t just holding its ground, it’s building a base for something bigger.

📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀

Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀

@Tiger_comments @TigerClub @TigerWire @TigerPicks @TigerStars @TigerObserver @Daily_Discussion